A roundup of developments and latest news from China (Dollar Tree), Germany (Bayer), India (Zydus Cadila), and the United States (Entera Bio, Torrent Pharma). China FDA Issues Warning Letter to…
Amgen Completes $13.4-Billion Acquisition of Celgene’s Otezla
Amgen has completed its $13.4-billion acquisition of Celgene’s Otezla (apremilast), a drug for treating moderate-to-severe plaque psoriasis and psoriatic arthritis. Celgene had divested the drug in connection with its $74-billion…
Merck and Co. has acquired Calporta Therapeutics, a developer of small-molecule agonists for treating Niemann-Pick C disease, a rare genetic disorder characterized by an inability of the body to transport…
US Senate Committee Holds Confirmation Hearing for Nominee for FDA Commissioner
The US Senate Committee on Health, Education, Labor & Pensions (HELP) held a confirmation hearing this week (November 20, 2019) for President Donald Trump’s nominee for the US Food and…
Lonza has announced that Marc Funk, Chief Executive Officer (CEO), will leave the company for personal reasons. The Board of Directors also announced that Albert Baehny, Chairman, will take on…
Recipharm To Acquire UK CDMO Consort Medical for $652 million
Recipharm, a CDMO of active pharmaceutical ingredients (APIs) and drug products, has agreed to acquire Consort Medical, the parent company of Aesica, a CDMO of APIs and drug products, and…
Viatris Is Name of New Company Formed from Merger of Mylan and Pfizer’s Generics Biz
Mylan and Pfizer have announced Viatris as the name of the new company to be formed by the planned combination of Mylan and Upjohn, Pfizer’s off-patent branded and generic established…
FDA OKs Pfizer’s Biosimilar of AbbVie’s Blockbuster Drug Humira
The US Food and Drug Administration (FDA) has approved Pfizer’s Abrilada (adalimumab-afzb) as a biosimilar to AbbVie’s blockbuster drug, Humira (adalimumab), an anti-inflammatory drug. Abrilada has been approved for the…
Lilly To Invest $400 M To Expand Manufacturing Facilities
Eli Lilly and Company has announced plans to invest $400 million in its manufacturing facilities at its Lilly Technology Center campus in Indianapolis, Indiana. The investment includes enhancements to existing…
Roche To Acquire Biopharma Company Promedior in $1.4-Bn Deal
Roche has agreed to acquire Promedior, a Lexington, Massachusetts-based clinical-stage biopharmaceutical company with a portfolio of molecules for treating serious fibrotic diseases, in a deal worth up to $1.4 billion.…
